Anaheim, CA, Dec. 13, 2017 (GLOBE NEWSWIRE) -- LiveWire Ergogenics, Inc. (OTC: LVVV), a company focused on research partnerships, product development and commercialization of cannabinoid-based products, continues its push into the medical and recreational marijuana business to become the premier supplier for genetics cloning. The company announced today that agreements have been made with a group of private investors to provide funding and equipment lease financing for future projects. Additionally, Bill Hodson, CEO of LiveWire, has been appointed to the action committee for the Inland Empire chapter of NORML, the National Organization to Reform Marijuana Laws.
LiveWire’s cloning greenhouse facilities and associated 4-acres of land continue to be improved with a water reclamation pond, power upgrades and security fences. The design of this “turnkey property compound” is in the process of being adopted and expanded for additional greenhouses. Navigating the ever-changing compliance issues prior to increasing the capacity of the cloning operations is of paramount importance to LiveWire.
“While we have made significant progress towards our ultimate business goals and are very pleased with the progress to date with respect to our land development, there is still a lot to be achieved as the market heats up. I look forward to personally immerse myself even further into the marijuana compliance, permitting process and other related legal issues. It is a big challenge to be out-front on compliance issues to insure our nursery operation can grow to its potential and realize the expected returns for our shareholders by providing quality clone strains and clean genetics to the exploding cannabis markets,” Hodson stated.
The new funding agreement will further develop the existing property, provide state of the art equipment, new greenhouses, develop additional locations within California and other states and facilitate new business acquisitions. This funding accelerates the push into the marijuana sector and LiveWire’s effort for building a sustainable and profitable business, short and long term.
Currently, LiveWire does not grow, harvest or distribute marijuana that violates any local, state or federal laws.
About LiveWire Ergogenics, Inc.
LiveWire Ergogenics, Inc. (LVVV) is focused on identifying and monetizing current and future trends in the health and wellness industry. The Company is focused on establishing research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with a large “sufferer” population for human and veterinarian applications. This includes the cloning of cannabis strains to produce positive medicinal results, dosing verification of zero pesticide products for quality brands and development and licensing of high-quality cannabinoid based products and services. The team at LiveWire Ergogenics has a passion for research and is committed to generate and implement innovative ideas and produce high-quality products that satisfy an increasing demand in this fast-growing industry.
Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements may include, without limitation, financial projections, statements regarding the plans and objectives of management for future operations, the development, regulatory approvals and commercialization of the Company’s products, or any of the Company’s other proposed products, systems or services.
Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances and actual events may differ considerably. Factors that may cause actual results to differ materially from any projections may include, without limitation, the Company’s inability to obtain additional financing, delays in the development of its products, the impact of significant government regulation in the cannabis industry, existing or increased competition, results of arbitration and litigation, stock volatility and illiquidity, and the Company’s failure to implement the Company’s business plans or strategies. The Company assumes no obligation to update any forward-looking statements to reflect any event or circumstance that may arise after the date of this release.